Back
Bright Minds Biosciences Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50
DRUG
Bright Minds Biosciences
Last Price:
$32.31
Seasonality Move:
-4.26%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and DRUG is experiencing slight selling pressure.
Bright Minds Biosciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.89 | Sell |
| 20-day SMA: | 32.48 | Buy |
| 50-day SMA: | 34.79 | Sell |
| 200-day SMA: | 25.31 | Buy |
| 8-day EMA: | 32.74 | Sell |
| 20-day EMA: | 30.21 | Buy |
| 50-day EMA: | 21.25 | Buy |
| 200-day EMA: | 7.57 | Buy |
Bright Minds Biosciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.94 | Buy |
| Relative Strength Index (14 RSI): | 48.32 | Sell |
| Chaikin Money Flow: | -11116 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.54 - 35.66) | Sell |
| Bollinger Bands (100): | (32.49 - 40.61) | Sell |
Bright Minds Biosciences Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Bright Minds Biosciences Stock
Is Bright Minds Biosciences Stock a Buy?
-
Bright Minds Biosciences share price is 32.71 while DRUG 8-day simple moving average is 32.89, which is a Sell signal.
-
The stock price of DRUG is 32.71 while Bright Minds Biosciences 20-day SMA is 32.48, which makes it a Buy.
-
Bright Minds Biosciences 50-day simple moving average is 34.79 while DRUG share price is 32.71, making it a Sell technically.
-
DRUG stock price is 32.71 and Bright Minds Biosciences 200-day simple moving average is 25.31, creating a Buy signal.
DRUG Technical Analysis vs Fundamental Analysis
Sell
50
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy or a Sell?
-
Bright Minds Biosciences stock is rated a SellThe current Bright Minds Biosciences [DRUG] share price is $32.71. The Score for DRUG is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Bright Minds Biosciences Stock Info
Market Cap:
230.4M
Price in USD:
32.71
Share Volume:
50.4K
Bright Minds Biosciences 52-Week Range
52-Week High:
79.02
52-Week Low:
0.93
Sell
50
Bright Minds Biosciences (DRUG)
is a Sell
Bright Minds Biosciences Share Price Forecast
-
What is the Bright Minds Biosciences stock price today?The Bright Minds Biosciences stock price is 32.71 USD today.
-
Will DRUG stock go up or go down?Bright Minds Biosciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Bright Minds Biosciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Bright Minds Biosciences is overvalued.
Is Bright Minds Biosciences Stock a Buy?
-
Bright Minds Biosciences share price is 32.71 while DRUG 8-day exponential moving average is 32.74, which is a Sell signal.
-
The stock price of DRUG is 32.71 while Bright Minds Biosciences 20-day EMA is 30.21, which makes it a Buy.
-
Bright Minds Biosciences 50-day exponential moving average is 21.25 while DRUG share price is 32.71, making it a Buy technically.
-
DRUG stock price is 32.71 and Bright Minds Biosciences 200-day simple moving average is 7.57, creating a Buy signal.
Fundamental Analysis of Bright Minds Biosciences
Is Bright Minds Biosciences a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.58 per share, and a decrease next year of $1.66 per share.
Technical Analysis of Bright Minds Biosciences
Should I short Bright Minds Biosciences stock?
-
DRUG Moving Average Covergence Divergence (MACD) indicator is 3.94, suggesting Bright Minds Biosciences is a Buy
-
Bright Minds Biosciences Relative Strength Index (RSI) is 48.32, which suggest Bright Minds Biosciences is oversold
-
The Bollinger Bands (25) for Bright Minds Biosciences is (30.54 - 35.66), which suggest Bright Minds Biosciences is a Sell
-
The Bollinger Bands (100) for Bright Minds Biosciences is (32.49 - 40.61), which suggest Bright Minds Biosciences is a Sell
* Bright Minds Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.